Press release
Comprehensive Industry Report Offers Forecast and Analysis on Pharmerging Contract Manufacturing Market ( 2016-2026)
Pharmerging markets indicate the most promising emerging markets in the pharmaceutical domain. Most of these markets are currently exhibiting growth rates moderate to high indicating sustainable demand prospects. The global pharmaceutical market is projected to expand at CAGR of 4–7% between 2015 and 2026 to reach US$1.5 trillion by 2026. This indicates revenues from companies at ex-manufacturer price levels excluding rebates and discounts. Industry experts note that the U.S. and pharmerging markets are expected to account for more than 60% of sales and 80% of sales growth over the next five years. Contract manufacturing of pharmaceuticals is witnessing steady acceleration in pharmerging markets given high demand for medicines in these countries. For example, consumer medicines form a substantially large portion of pharmerging markets and manufacturers want to source the production of these medicines in the target market themselves. Given the growing complexity in supply-chain of highly potent drugs (both small molecules and biologics); there is a growing trend of outsourcing early-stage analytical, formulation, and commercial development of the medicines. This shift offers CDMOs more opportunities to partner and offer services within the drug product lifecycle. Specifically experts notes that outsourcing the bulk manufacturing of drugs is gradually gaining traction in countries in Asia-Pacific.Pharmerging Contract Manufacturing Market: Drivers and Restraints
Growing demand for generics in pharmerging markets due to affordability issues is the single most important revenue growth driver of the CMOs in pharmerging markets. Favorable government policies promoting localization are expected to create pull factors for generally manufacturers of generic products rather than originals. Companies having large portfolios, integrated distributors, strong stakeholder relationships, and quick decision-making processes in place are expected to witness dynamic growth compared to others. Other success factors of CMOs include proven record of accomplishment in continuity of supply, unchallengeable quality, competitive pricing and presence of adequate skilled workforce.
Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2482
Barriers include non-availability of adequate sterile infrastructure to manufacture injectable drugs and other aseptic formulations. Availability of skilled labor to assist manufacturing of highly potent APIs, cytotoxic drugs, other biologics are factors expected to halt production. Other barriers include limited access to foreign capital, lack of transparency in emerging markets and fluctuations in government policies.
Pharmerging Contract Manufacturing Market: Segmentation
Global pharmerging contract manufacturing market can be segmented in multiple ways. A few these segmentation approaches are based on Product, Class, Therapeutic Area, and, CMO type.
Based on the product class, the pharmerging contract manufacturing market is segmented into the following:
Branded Drugs
Branded Generics
Generics
Based on the drug class, market is segmented as:
Small molecule Drugs
Generic Drugs
Highly-potent drugs and cytotoxic drugs
Large Molecule Drugs
Monoclonal Antibodies
Vaccines
Interferon
Insulin and analogs
Others
Based on the therapeutic class, the market is segmented into the following:
Cardiovascular
Oncology
Diabetes
Infectious Diseases
Others
Pharmerging Contract Manufacturing Market: Market Overview
The market for CMOs is gaining traction across regions and market given CMOs are increasingly being considered strategic partners, in production through sharing greater amounts of the portfolio volume, and less as step-in organizations to smooth out manufacturing peaks.
Geographically, pharmerging contract manufacturing market is classified into regions viz. Latin America, Europe, APAJ, Middle East and Africa. In terms of geography, Europe accounts for the largest market share followed by APAC. Favorable policies, regulations and sophisticated healthcare infrastructure with increasing FDA approvals is expected to drive revenue growth of the market in the near future. Markets in Asia Pacific represent the fastest growth for generic drugs owing to growing number of CMOs, CROs and CDMOs coupled with development of favorable infrastructure across countries in the region. It is predicted that much traction in solid dosage contract manufacturing could be noted in markets such as China and India as more facilities in these countries receive U.S. and EU CGMP certifications and approvals. Much activity is expected to be noted on both clinical and commercial phases over the near term in these pharmerging markets.
Visit For TOC@https://www.futuremarketinsights.com/toc/rep-gb-2482
Few key players in pharmerging contract manufacturing market are Cipla, Piramal Healthcare, Aurobindo, Jubilant Life Sciences, Zydus Cadila, Alkem, Intas, Lupin, Torrent, FDC, etc. apart from includes and others. Some of China’s leading CMOs include Asymchem Laboratories, Beijing Second Pharmaceutical, Chongqing Huapont Pharmaceutical, Porton Fine Chemicals, Shandong Xinhua Pharmaceutical, etc. These players are entering into strategic collaborations, mergers & acquisitions, and product portfolio expansions, which are their key sustainability strategies to maintain their profit margins in the long run. Also many startup companies’ have entered in this lucrative market space to capitalize over the opportunities present in therapeutic laser system market.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Industry Report Offers Forecast and Analysis on Pharmerging Contract Manufacturing Market ( 2016-2026) here
News-ID: 714202 • Views: …
More Releases from Future Market Insights

AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses…

Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels.
As e-commerce continues to penetrate global…

HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications.
The expansion…

Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across…
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…